Tofanil 5 (Tofacitinib (5mg))

Tofanil-5 contains Tofacitinib (5 mg) an oral Janus kinase (JAK) inhibitor used for the treatment of moderate to severe rheumatoid arthritis psoriatic arthritis and ulcerative colitis. Tofacitinib works by interfering with the inflammatory process in the body helping to alleviate symptoms such as pain swelling and joint damage. It is particularly useful for patients who have not responded adequately to traditional disease-modifying antirheumatic drugs (DMARDs) offering an effective option to improve quality of life and manage chronic inflammatory conditions.